Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(11):1713–1721. doi: 10.1054/bjoc.2001.2177

High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR

L Perey 1, J Benhattar 1, R Peters 1, P Jaunin 1, S Leyvraz 1
PMCID: PMC2363973  PMID: 11742493

Abstract

In small-cell lung carcinoma (SCLC) tumour cell contamination of leukaphereses is unknown. The present study was performed to define appropriate markers for reverse transcriptase polymerase chain reaction (RT-PCR), then to assess the contamination rate of leukaphereses and corresponding bone marrow samples. Immunocytochemistry (ICC) and RT-PCR methods were also compared. Among the 33 patients included, analyses were performed in 16 who had multiple leukaphereses and 17 who had only bone marrow. Leukapheresis products and bone marrow were analysed by ICC using several specific monoclonal antibodies against neural-cell adhesion molecule (N-CAM), epithelial glycoprotein (EGP-40) and cytokeratins (CK). Samples were also analyzed by RT-PCR for expression for N-CAM, synaptophysin, neuron-specific enolase, chromogranin, cytokeratin-18/-19, CEA, EGP-40, apomucin type 1 (MUC-1) and human endothelial cell-specific molecule (ESM-1). Using ICC staining, contaminating tumour cells were detected in 34% of leukaphereses (27% in patients with limited disease and 43% in those with extensive disease). N-CAM was the most reliable marker for detection of contamination. For RT-PCR, CK-19 and CEA were the only appropriate markers. Positive signal rate in leukaphereses increased to 78% (89% for patients with limited disease and 67% for extensive disease). In bone marrow, both techniques were in agreement whereas in leukaphereses, RT-PCR was better than ICC. A high rate of tumour cell contamination was demonstrated not only in bone marrow but also in leukaphereses from SCLC patients. The most appropriate technique was RT-PCR mainly in patients with limited disease. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: tumour cell contamination, leucaphereses, SCLC, RT-PCR, immunocytochemistry staining

Full Text

The Full Text of this article is available as a PDF (105.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arriagada R., Le Chevalier T., Pignon J. P., Rivière A., Monnet I., Chomy P., Tuchais C., Tarayre M., Ruffié P. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med. 1993 Dec 16;329(25):1848–1852. doi: 10.1056/NEJM199312163292504. [DOI] [PubMed] [Google Scholar]
  2. Beiske K., Myklebust A. T., Aamdal S., Langholm R., Jakobsen E., Fodstad O. Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol. 1992 Sep;141(3):531–538. [PMC free article] [PubMed] [Google Scholar]
  3. Benhattar J., Perey L., Peters R., Leyvraz S. Reverse transcriptase-polymerase chain reaction and islet cell carcinoma: not antagonist, but complementary tools. J Clin Oncol. 1998 Feb;16(2):806–807. doi: 10.1200/JCO.1998.16.2.806. [DOI] [PubMed] [Google Scholar]
  4. Blobel G. A., Gould V. E., Moll R., Lee I., Huszar M., Geiger B., Franke W. W. Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest. 1985 Jan;52(1):39–51. [PubMed] [Google Scholar]
  5. Bostick P. J., Chatterjee S., Chi D. D., Huynh K. T., Giuliano A. E., Cote R., Hoon D. S. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol. 1998 Aug;16(8):2632–2640. doi: 10.1200/JCO.1998.16.8.2632. [DOI] [PubMed] [Google Scholar]
  6. Braun S., Pantel K. Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat. 1998;52(1-3):201–216. doi: 10.1023/a:1006164914610. [DOI] [PubMed] [Google Scholar]
  7. Brenner M. K., Rill D. R., Moen R. C., Krance R. A., Mirro J., Jr, Anderson W. F., Ihle J. N. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet. 1993 Jan 9;341(8837):85–86. doi: 10.1016/0140-6736(93)92560-g. [DOI] [PubMed] [Google Scholar]
  8. Broers J. L., Carney D. N., Klein Rot M., Schaart G., Lane E. B., Vooijs G. P., Ramaekers F. C. Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci. 1986 Jul;83:37–60. doi: 10.1242/jcs.83.1.37. [DOI] [PubMed] [Google Scholar]
  9. Broers J. L., Rot M. K., Oostendorp T., Huysmans A., Wagenaar S. S., Wiersma-van Tilburg A. J., Vooijs G. P., Ramaekers F. C. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res. 1987 Jun 15;47(12):3225–3234. [PubMed] [Google Scholar]
  10. Brugger W., Bross K. J., Glatt M., Weber F., Mertelsmann R., Kanz L. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood. 1994 Feb 1;83(3):636–640. [PubMed] [Google Scholar]
  11. Ettinger D. S., Karp J. E., Abeloff M. D., Burke P. J., Braine H. G. Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep. 1978 Mar;62(3):413–424. [PubMed] [Google Scholar]
  12. Farha P., Spitzer G., Valdivieso M., Dicke K. A., Zander A., Dhingra H. M., Minnhaar G., Vellekoop L., Verma D. S., Umsawasdi T. High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer. 1983 Oct 15;52(8):1351–1355. doi: 10.1002/1097-0142(19831015)52:8<1351::aid-cncr2820520802>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  13. Fields K. K., Elfenbein G. J., Trudeau W. L., Perkins J. B., Janssen W. E., Moscinski L. C. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol. 1996 Jun;14(6):1868–1876. doi: 10.1200/JCO.1996.14.6.1868. [DOI] [PubMed] [Google Scholar]
  14. Franklin W. A., Glaspy J., Pflaumer S. M., Jones R. B., Hami L., Martinez C., Murphy J. R., Shpall E. J. Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone. Blood. 1999 Jul 1;94(1):340–347. [PubMed] [Google Scholar]
  15. Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med. 1991 Nov 28;325(22):1525–1533. doi: 10.1056/NEJM199111283252201. [DOI] [PubMed] [Google Scholar]
  16. Helfrich W., ten Poele R., Meersma G. J., Mulder N. H., de Vries E. G., de Leij L., Smit E. F. A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood. Br J Cancer. 1997;76(1):29–35. doi: 10.1038/bjc.1997.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hirsch F., Hansen H. H., Dombernowsky P., Hainau B. Bone-marrow examination in the staging of small-cell anaplastic carcinoma of the lung with special reference to subtyping. An evaluation of 203 consecutive patients. Cancer. 1977 Jun;39(6):2563–2567. doi: 10.1002/1097-0142(197706)39:6<2563::aid-cncr2820390638>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  18. Kim J., Kaye F. J., Henslee J. G., Shively J. E., Park J. G., Lai S. L., Linnoila R. I., Mulshine J. L., Gazdar A. F. Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer. 1992 Nov 11;52(5):718–725. doi: 10.1002/ijc.2910520509. [DOI] [PubMed] [Google Scholar]
  19. Krismann M., Todt B., Schröder J., Gareis D., Müller K. M., Seeber S., Schütte J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol. 1995 Nov;13(11):2769–2775. doi: 10.1200/JCO.1995.13.11.2769. [DOI] [PubMed] [Google Scholar]
  20. Lambrechts A. C., van 't Veer L. J., Rodenhuis S. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol. 1998 Dec;9(12):1269–1276. doi: 10.1023/a:1008445604263. [DOI] [PubMed] [Google Scholar]
  21. Lassalle P., Molet S., Janin A., Heyden J. V., Tavernier J., Fiers W., Devos R., Tonnel A. B. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996 Aug 23;271(34):20458–20464. doi: 10.1074/jbc.271.34.20458. [DOI] [PubMed] [Google Scholar]
  22. Leyvraz S., Perey L., Rosti G., Lange A., Pampallona S., Peters R., Humblet Y., Bosquée L., Pasini F., Marangolo M. Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation. J Clin Oncol. 1999 Nov;17(11):3531–3539. doi: 10.1200/JCO.1999.17.11.3531. [DOI] [PubMed] [Google Scholar]
  23. Luppi M., Morselli M., Bandieri E., Federico M., Marasca R., Barozzi P., Ferrari M. G., Savarino M., Frassoldati A., Torelli G. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol. 1996 Aug;7(6):619–624. doi: 10.1093/oxfordjournals.annonc.a010680. [DOI] [PubMed] [Google Scholar]
  24. Moss T. J., Sanders D. G., Lasky L. C., Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood. 1990 Nov 1;76(9):1879–1883. [PubMed] [Google Scholar]
  25. Muggia F. M., Krezoski S. K., Hansen H. H. Cell kinetic studies in patients with small cell carcinoma of the lung. Cancer. 1974 Nov;34(5):1683–1690. doi: 10.1002/1097-0142(197411)34:5<1683::aid-cncr2820340516>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  26. Pasini F., Pelosi G., Mostacci R., Santo A., Masotti A., Spagnolli P., Recaldin E., Cetto G. L. Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations. Ann Oncol. 1995 Jan;6(1):86–88. doi: 10.1093/oxfordjournals.annonc.a059056. [DOI] [PubMed] [Google Scholar]
  27. Passos-Coelho J. L., Ross A. A., Kahn D. J., Moss T. J., Davis J. M., Huelskamp A. M., Noga S. J., Davidson N. E., Kennedy M. J. Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol. 1996 Sep;14(9):2569–2575. doi: 10.1200/JCO.1996.14.9.2569. [DOI] [PubMed] [Google Scholar]
  28. Pettengell R., Woll P. J., Thatcher N., Dexter T. M., Testa N. G. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol. 1995 Jan;13(1):148–156. doi: 10.1200/JCO.1995.13.1.148. [DOI] [PubMed] [Google Scholar]
  29. Rill D. R., Santana V. M., Roberts W. M., Nilson T., Bowman L. C., Krance R. A., Heslop H. E., Moen R. C., Ihle J. N., Brenner M. K. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood. 1994 Jul 15;84(2):380–383. [PubMed] [Google Scholar]
  30. Ross A. A., Cooper B. W., Lazarus H. M., Mackay W., Moss T. J., Ciobanu N., Tallman M. S., Kennedy M. J., Davidson N. E., Sweet D. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood. 1993 Nov 1;82(9):2605–2610. [PubMed] [Google Scholar]
  31. Ross A. A. Minimal residual disease in solid tumor malignancies: a review. J Hematother. 1998 Feb;7(1):9–18. doi: 10.1089/scd.1.1998.7.9. [DOI] [PubMed] [Google Scholar]
  32. Schoenfeld A., Kruger K. H., Gomm J., Sinnett H. D., Gazet J. C., Sacks N., Bender H. G., Luqmani Y., Coombes R. C. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer. 1997 May;33(6):854–861. doi: 10.1016/s0959-8049(97)00014-2. [DOI] [PubMed] [Google Scholar]
  33. Shy S. W., Lee W. H., Chou M. C., Lai Y. S., Tu Y. C. Small cell lung carcinoma: clinicopathological, immunohistochemical, and ultrastructural study. J Surg Oncol. 1990 Nov;45(3):146–161. doi: 10.1002/jso.2930450304. [DOI] [PubMed] [Google Scholar]
  34. Souhami R. L., Finn G., Gregory W. M., Birkhead B. G., Buckman R., Edwards D., Goldstone A. H., Harper P. G., Spiro S. G., Tobias J. S. High-dose cyclophosphamide in small-cell carcinoma of the lung. J Clin Oncol. 1985 Jul;3(7):958–963. doi: 10.1200/JCO.1985.3.7.958. [DOI] [PubMed] [Google Scholar]
  35. Stahel R. A., Mabry M., Skarin A. T., Speak J., Bernal S. D. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol. 1985 Apr;3(4):455–461. doi: 10.1200/JCO.1985.3.4.455. [DOI] [PubMed] [Google Scholar]
  36. Steward W. P., von Pawel J., Gatzemeier U., Woll P., Thatcher N., Koschel G., Clancy L., Verweij J., de Wit R., Pfeifer W. Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol. 1998 Feb;16(2):642–650. doi: 10.1200/JCO.1998.16.2.642. [DOI] [PubMed] [Google Scholar]
  37. Thatcher N., Girling D. J., Hopwood P., Sambrook R. J., Qian W., Stephens R. J. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party. J Clin Oncol. 2000 Jan;18(2):395–404. doi: 10.1200/JCO.2000.18.2.395. [DOI] [PubMed] [Google Scholar]
  38. Weiss R. B. Small-cell carcinoma of the lung: therapeutic management. Ann Intern Med. 1978 Apr;88(4):522–531. doi: 10.7326/0003-4819-88-4-522. [DOI] [PubMed] [Google Scholar]
  39. Weiss W., Boucot K. R., Cooper D. A. The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer. 1970 Nov;26(5):965–970. doi: 10.1002/1097-0142(197011)26:5<965::aid-cncr2820260502>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  40. Woll P. J., Hodgetts J., Lomax L., Bildet F., Cour-Chabernaud V., Thatcher N. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. J Clin Oncol. 1995 Mar;13(3):652–659. doi: 10.1200/JCO.1995.13.3.652. [DOI] [PubMed] [Google Scholar]
  41. Yan P., Bosman F. T., Benhattar J. Tissue quality is an important determinant of telomerase activity as measured by TRAP assay. Biotechniques. 1998 Oct;25(4):660–662. doi: 10.2144/98254dt05. [DOI] [PubMed] [Google Scholar]
  42. Zhong X. Y., Kaul S., Diel I., Eichler A., Bastert G. Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products. J Cancer Res Clin Oncol. 1999;125(5):286–291. doi: 10.1007/s004320050275. [DOI] [PubMed] [Google Scholar]
  43. Zippelius A., Kufer P., Honold G., Köllermann M. W., Oberneder R., Schlimok G., Riethmüller G., Pantel K. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol. 1997 Jul;15(7):2701–2708. doi: 10.1200/JCO.1997.15.7.2701. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES